Bioray Biotech Co., Ltd(TW:7561)
NT$15.900.00 (0.00%)
TW:7561
Bioray Biotech Co., Ltd Revenue
NT$15.90
At close:0.00 (0.00%)
Bioray Biotech Co., Ltd (7561) Revenue
Bioray Biotech Co., Ltd Revenue
Bioray Biotech Co., Ltd had a revenue of 98.58M in the quarter ending Jun 30, 2026, with -9.22%. This bring the company's revenue in the last twelve months to 207.16M, Decreased 6.99%. In the fiscal year ending Dec 31, 2025, Bioray Biotech Co., Ltd had annual revenue of 222.72M with 10.42% growth.
- Revenue (ttm)
- 207.16M
- Revenue Growth
- -9.95%
- P/S Ratio
- 2.15
- Revenue/Employee
- TWD 2,819,304
- Employees
- 79
- Market Cap
- TWD 478.36M
Revenue Chart
Bioray Biotech Co., Ltd Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 222.72M | 21.01M | 10.42% |
| Dec 31, 2024 | 201.71M | 9.88M | 5.15% |
| Dec 31, 2023 | 191.83M | 1.23M | 0.65% |
| Dec 31, 2022 | 190.60M | 42.58M | 28.77% |
| Dec 31, 2021 | 148.02M | -8.28M | -5.30% |
| Dec 31, 2020 | 156.29M | -25.64M | -14.09% |
| Dec 31, 2019 | 181.93M | -3.56M | -1.92% |
| Dec 31, 2018 | 185.49M | 61.57M | 49.69% |
| Dec 31, 2017 | 123.92M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.